Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0K5HD
|
||||
| Former ID |
DIB010036
|
||||
| Drug Name |
LY-315902
|
||||
| Indication | Type 2 diabetes [ICD9: 250; ICD10:E11] | Discontinued in Phase 1 | [546563] | ||
| Company |
Eli Lilly & Co
|
||||
| Structure |
|
Download2D MOL |
|||
| Canonical SMILES |
[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C<br />(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC<br />(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C<br />@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=<br />O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)NCC(=O)N[C@H](C(=<br />O)NCC(=O)O)CCCNC(=N)N)CCCCNC(=O)CCCCCCC)C(C)C)CC(C)C)Cc<br />1c[nH]c2c1cccc2)C)[C@H](CC)C)Cc1ccccc1)CCC(=O)O)CCCNC(=<br />N)N)C)C)CCC(=O)N)CCC(=O)O)CC(C)C)Cc1ccc(cc1)O)CO)CO)C(C<br />)C)CC(=O)O)CO)(NC(=O)[C@@H](NC(=O)[C@@H](NC(=O)CNC(=O)[<br />C@@H](NC(=O)[C@@H](NC(=O)CCc1[nH]cnc1)C)CCC(=O)O)[C@H](<br />O)C)Cc1ccccc1)[C@H](O)C
|
||||
| CAS Number |
CAS 176435-10-2
|
||||
| Target and Pathway | |||||
| Target(s) | Glucagon-like peptide 1 receptor | Target Info | Modulator | [526351] | |
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.